Top Markets
Coin of the day
Wuhan Hiteck Biological Pharma Co.,Ltd Wuhan Hiteck Biological Pharma Co.,Ltd

Wuhan Hiteck Biological Pharma Co.,Ltd

300683
株式のランク #13466
Wuhan Hiteck Biological Pharma Co.,Ltd is a biopharmaceutical enterprise... Wuhan Hiteck Biological Pharma Co.,Ltd is a biopharmaceutical enterprise operating in China, primarily engaged in the research, development, manufacturing, and commercialization of bio-engineered products and lyophilized injectable medications. The company's extensive product portfolio encompasses a variety of pharmaceutical solutions, such as Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye acyclovir tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository; Xunkeyuan tinidazole suppository; and Shufu nimodipine sustained-release tablets. Beyond therapeutics, Wuhan Hiteck also provides a comprehensive array of diagnostic kits. These include tests for measles virus and rubella virus nucleic acid, mycoplasma isolation and identification, bacterial vaginosis rapid detection, measles virus IgG antibodies, and the coronavirus N-protein. Furthermore, the firm supplies active pharmaceutical ingredients (APIs) and their chemical intermediates, notably Lopinavir and Ritonavir. Its core therapeutic areas of focus are the nervous system and oncology. Established in 1992, Wuhan Hiteck Biological Pharma Co.,Ltd is headquartered in Wuhan, China.
株価
$3.71
時価総額
$486.16M
変化(1日)
-0.97%
変化(1年)
-45.64%
CN
取引 Wuhan Hiteck Biological Pharma Co.,Ltd (300683)

カテゴリー

Wuhan Hiteck Biological Pharma Co.,Ltd(300683)の株価履歴
終値の最高値: $4.14 (2026-08-01)

終値の最安値: $9.02 (2017-08-01)
Wuhan Hiteck Biological Pharma Co.,Ltd の株価履歴(2017 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 12.03%
2025 12.89%
2024 -29.37%
2023 -7.73%
2022 -31.14%
2021 20.37%
2020 60.25%
2019 2.10%
2018 -50.10%
2017 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$171.67 -
DE
$164.88 30.29%
DE
$37.61 25.11%
JP
$21.90 21.12%
IN
$218.36 25.22%
CH